Clinical Trial Update: A First in Human Study of PLT012 in Participants With Solid Tumor Cancers [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 study of PLT012 in participants with solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PLT012

Snippet

Sponsor: Pilatus Biosciences Inc | Conditions: Advanced Malignant Solid Tumor, Solid Tumor Cancer | Phase 1 | Status: RECRUITING